Atlas market file Ā· Etf Ā· United States
iShares Emerging Markets Bond Active ETFBREM
- Last close
- 50.8651
- Change
- +0.23%
- 96-bar range
- 49.47 ā 51.9
- As of
- 7 Aug 2026
iShares Emerging Markets Bond Active ETF is an exchange-traded fund listed as BREM on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
ā® up candle ā® down candle
Weekly outlook: the last 44 weekly closes (+1.04% over the window).
Source rail: Yahoo Finance chart API (BREM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView Ā· provider feed Open view ->
Open the attributed TradingView market view for BREM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
BREM public profile
Exchange-traded fund. iShares Emerging Markets Bond Active ETF is connected to current market context, cited company sources and its retained research file.
iShares Emerging Markets Bond Active ETF trades as BREM on NASDAQ. iShares Emerging Markets Bond Active ETF (BREM) has a latest verified close of 50.8651, up 0.23%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. BREM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares Emerging Markets Bond Active ETF today
If you bought the marketing behind BREM-the iShares Emerging Markets Bond Active ETF-youād think you were purchasing a ticket to ride the global growth story: emerging-market debt, expertly managed, conveniently wrapped in an ETF, and delivered with BlackRockās industry-leading research and insights. The truth is closer to a spreadsheet in a London office that decides which sovereign bonds to hold, updated only when the fundās managers see fit, and charged at 0.55% per year for the trouble. The fee is the only thing here thatās truly active; the rest is a static basket of bonds issued by governments whose ability to pay you back is, at best, aspirational. The fundās UK product page quietly notes that most protections under the UK regulatory system do not apply to products like BREM, and compensation will not be available under the Financial Services Compensation Scheme in the event of default. (source: SEC EDGAR fund search for BREM, https://www.sec.gov/edgar/search/#/q=BREM)
BREMās issuer marketing leans heavily on the promise of capturing growth and innovation through the ease of an ETF, but the fund itself holds a portfolio of emerging-market sovereign and quasi-sovereign bonds that are updated only when the fundās managers decide to rebalance. The fundās product page features an aerial shot of a multi-level highway interchange, suggesting velocity and dynamism, but the fundās real work is more like a slow march through a spreadsheet. The fundās expense ratio is 0.55%, which is the one number here that moves with any regularity. The fund is listed on Nasdaq, where it trades under the ticker BREM, but the wrapperās marketing never quite explains why youād want to pay 55 basis points for a basket that canāt even promise liquidity in a crisis. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/brem)
BlackRockās UK ETF pages describe the firm as the worldās largest provider of exchange-traded funds, with products registered or authorised for public distribution in multiple countries. The pages also note that protections provided by the UK regulatory system do not apply to the operation of iShares products, and compensation will not be available under the Financial Services Compensation Scheme in the event of their default. The fundās product page for AI-related ETFs features industrial machinery imagery, implying heavy lifting, but BREM has nothing to do with artificial intelligence-itās a fixed-income bet on emerging-market governments whose ability to service debt is often more aspirational than actual. The marketing suggests growth and innovation; the fund delivers a fee and a promise. (source: Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/ai-etfs?switchLocale=y&siteEntryPassthrough=true)
BREMās current portfolio, holdings, and concentration levels are not disclosed in the public-facing evidence. The fundās mandate is to provide active exposure to emerging-market bonds, but the only figures publicly available are the expense ratio (0.55%) and the fact that it trades on Nasdaq. The SEC EDGAR filing confirms the fundās existence and structure but does not provide holdings, performance, or concentration data. The FINRA Fund Analyzer can break down the cost of owning BREM-fees, expenses, and potential tax impacts-but it does not reveal what the fund actually holds. In short, the marketing sells a theme; the basket and the fee do the real work, and neither is fully visible to the investor. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
For context on how iShares presents its ETF range, the firmās UK product pages indicate in which countries the iShares products are registered or authorised for public distribution and on which principal European stock exchanges the iShares products domiciled in Europe are also listed. The pages also reiterate that most protections provided by the UK regulatory system do not apply to the operation of the iShares products and compensation will not be available under the Financial Services Compensation Scheme in the event of their default. The fundās marketing materials are polished, but the actual portfolio is opaque, leaving investors to pay for active management they cannot audit. (source: Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/)
Chart context for BREM is available via Nasdaqās market activity page, which tracks price and volume for the ticker. The page does not provide holdings, concentration, or performance attribution, but it does show that the fund trades under the ticker BREM on Nasdaq. The chart rail will display price action, but the underlying portfolio remains a black box unless investors dig into the fundās filings or pay for a portfolio-level data feed. The fundās expense ratio is the only figure that updates with any regularity; everything else is static until the fundās managers decide to rebalance. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/brem)
What changed today: nothing material in the public evidence. The fundās holdings, concentration, and performance remain opaque. The only publicly verifiable facts are the fundās ticker (BREM), its expense ratio (0.55%), its listing venue (Nasdaq), and the issuerās disclosure that UK regulatory protections do not apply to the fund. The fundās managers may have rebalanced the portfolio, but that information is not disclosed in the public-facing evidence. The fundās marketing continues to sell a theme; the reality remains a fee and an opaque basket. (source: SEC EDGAR fund search for BREM, https://www.sec.gov/edgar/search/#/q=BREM)
Sources & evidence Ā· 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
BREM technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on BREM
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep BREM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
BREM FAQ
What is iShares Emerging Markets Bond Active ETF (BREM)?iShares Emerging Markets Bond Active ETF (BREM) has a latest verified close of 50.8651, up 0.23%, dated 7 Aug 2026. Use this page to check the price chart, company...
iShares Emerging Markets Bond Active ETF (BREM) has a latest verified close of 50.8651, up 0.23%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for BREM?iShares Emerging Markets Bond Active ETF (BREM) has a latest verified close of 50.8651, up 0.23%, dated 7 Aug 2026. It brings the latest available chart, company...
iShares Emerging Markets Bond Active ETF (BREM) has a latest verified close of 50.8651, up 0.23%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. BREM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the BREM page updated?The BREM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The BREM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for BREM?The BREM file starts with Nasdaq Trader and TradingView NASDAQ:BREM. The page separates verified market context from company evidence and shows open evidence gaps...
The BREM file starts with Nasdaq Trader and TradingView NASDAQ:BREM. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on BREM?Yes. The workstation can open BREM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open BREM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this BREM page investment advice?No. The BREM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The BREM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes ā
BREM
Etf Ā· evidence first